Editorial

In 2013, the 22th meeting of experimental Neurooncology again took place in Minden. From April 26th to 27th experts in the field of pediatric oncology, neurosurgery, neuropathology, radiotherapy, pharmacology, biology and molecular biology come together to discuss on recent developments in the field of pediatric neurooncology. Participants from the German Cancer Research Centre in Heidelberg presented their work on new tumor models to explore genetic alterations within different pediatric brain tumor types. New strategies for preclinical testing of brain tumor susceptibility to new antitumor drugs were presented…